c9-Heptadecenoic acid acid

Details

Top
Internal ID a6bec9b7-dfc9-4d08-8d20-f447f225d6ab
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acids and conjugates > Long-chain fatty acids
IUPAC Name heptadec-9-enoic acid
SMILES (Canonical) CCCCCCCC=CCCCCCCCC(=O)O
SMILES (Isomeric) CCCCCCCC=CCCCCCCCC(=O)O
InChI InChI=1S/C17H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(18)19/h8-9H,2-7,10-16H2,1H3,(H,18,19)
InChI Key QSBYPNXLFMSGKH-UHFFFAOYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C17H32O2
Molecular Weight 268.40 g/mol
Exact Mass 268.240230259 g/mol
Topological Polar Surface Area (TPSA) 37.30 Ų
XlogP 6.90
Atomic LogP (AlogP) 5.72
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 14

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of c9-Heptadecenoic acid acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9947 99.47%
Caco-2 + 0.8119 81.19%
Blood Brain Barrier + 0.8250 82.50%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Plasma membrane 0.5465 54.65%
OATP2B1 inhibitior - 0.8501 85.01%
OATP1B1 inhibitior - 0.3622 36.22%
OATP1B3 inhibitior - 0.5698 56.98%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.6872 68.72%
P-glycoprotein inhibitior - 0.8917 89.17%
P-glycoprotein substrate - 0.9649 96.49%
CYP3A4 substrate - 0.6902 69.02%
CYP2C9 substrate + 0.6276 62.76%
CYP2D6 substrate - 0.8766 87.66%
CYP3A4 inhibition - 0.9295 92.95%
CYP2C9 inhibition - 0.8972 89.72%
CYP2C19 inhibition - 0.9467 94.67%
CYP2D6 inhibition - 0.9545 95.45%
CYP1A2 inhibition + 0.9107 91.07%
CYP2C8 inhibition - 0.9384 93.84%
CYP inhibitory promiscuity - 0.9349 93.49%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7035 70.35%
Carcinogenicity (trinary) Non-required 0.7021 70.21%
Eye corrosion + 0.9611 96.11%
Eye irritation + 0.9549 95.49%
Skin irritation + 0.8622 86.22%
Skin corrosion + 0.6450 64.50%
Ames mutagenesis - 0.9900 99.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7502 75.02%
Micronuclear - 1.0000 100.00%
Hepatotoxicity - 0.7625 76.25%
skin sensitisation + 0.8676 86.76%
Respiratory toxicity - 0.7111 71.11%
Reproductive toxicity - 0.7866 78.66%
Mitochondrial toxicity + 0.5625 56.25%
Nephrotoxicity - 0.7161 71.61%
Acute Oral Toxicity (c) IV 0.8289 82.89%
Estrogen receptor binding - 0.6998 69.98%
Androgen receptor binding - 0.8405 84.05%
Thyroid receptor binding + 0.6638 66.38%
Glucocorticoid receptor binding - 0.7732 77.32%
Aromatase binding - 0.8797 87.97%
PPAR gamma + 0.8622 86.22%
Honey bee toxicity - 0.9960 99.60%
Biodegradation + 0.9250 92.50%
Crustacea aquatic toxicity + 0.8900 89.00%
Fish aquatic toxicity + 0.9649 96.49%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL239 Q07869 Peroxisome proliferator-activated receptor alpha 600 nM
IC50
via Super-PRED
CHEMBL2219 P35236 Protein-tyrosine phosphatase LC-PTP 801 nM
IC50
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3060 Q9Y345 Glycine transporter 2 97.97% 99.17%
CHEMBL2581 P07339 Cathepsin D 95.56% 98.95%
CHEMBL4769 O95749 Geranylgeranyl pyrophosphate synthetase 95.16% 92.08%
CHEMBL230 P35354 Cyclooxygenase-2 94.14% 89.63%
CHEMBL1781 P11387 DNA topoisomerase I 93.36% 97.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.93% 96.09%
CHEMBL221 P23219 Cyclooxygenase-1 87.65% 90.17%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 85.24% 96.95%
CHEMBL2265 P23141 Acyl coenzyme A:cholesterol acyltransferase 84.84% 85.94%
CHEMBL3892 Q99500 Sphingosine 1-phosphate receptor Edg-3 83.86% 97.29%
CHEMBL2001 Q9H244 Purinergic receptor P2Y12 83.06% 96.00%
CHEMBL3359 P21462 Formyl peptide receptor 1 82.12% 93.56%

Cross-Links

Top
PubChem 3014063
NPASS NPC126750
LOTUS LTS0068781
wikiData Q104196143